Akira Matsutani

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

Oral administration of Blautia wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiota

Koji Hosomi, Mayu Saito, Jonguk Park et al. · Nature Communications · 2022 · 427 citations · Full text

Life Sciences, Microbiology, Nutrition +16

The Pro12→Ala Substitution in PPAR-γ Is Associated With Resistance to Development of Diabetes in the General Population

Hiroyuki Mori, Hiroshi Ikegami, Yoshihiko Kawaguchi et al. · Diabetes · 2001 · 239 citations · Full text

Medicine, Endocrinology, Genetics +15

Leptin Induces Proliferation of Pancreatic β Cell Line MIN6 through Activation of Mitogen-Activated Protein Kinase

Katsuya Tanabe, Shigeru Okuya, Yukio Tanizawa et al. · Biochemical and Biophysical Research Communications · 1997 · 134 citations

Life Sciences, Cell Biology, Endocrinology +14

Troglitazone Treatment Increases Plasma Vascular Endothelial Growth Factor in Diabetic Patients and Its mRNA in 3T3-L1 Adipocytes

Masahiro Emoto, Takatoshi Anno, Yutaka Satō et al. · Diabetes · 2001 · 92 citations · Full text

Medicine, Endocrinology, Pharmacology +17